Jonathan Yingling

Technik-/Wissenschafts-/F&E-Leiter bei ARCUS BIOSCIENCES, INC.

55 Jahre

Health Technology

Consumer Services

Aktive Positionen von Jonathan Yingling

Unternehmen	Position	Beginn	Ende
ARCUS BIOSCIENCES, INC.	Technik-/Wissenschafts-/F&E-Leiter	01.01.2020	-

Unternehmen	Position	Beginn	Ende
Idera Pharmaceuticals, Inc. Idera Pharmaceuticals, Inc. BiotechnologyHealth Technology Idera Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which focuses on the clinical development, and commercialization of drug candidates for both oncology and rare disease indications. The company was founded by Paul C. Zamecnik, Sudhir A. Agrawal, and James B. Wyngaarden on May 25, 1989 and is headquartered in Exton, PA.	Technik-/Wissenschafts-/F&E-Leiter	01.01.2018	31.01.2020
	Corporate Officer/Principal	06.02.2017	01.01.2018
BRISTOL-MYERS SQUIBB COMPANY	Corporate Officer/Principal	01.06.2013	01.10.2015
DNIB UNWIND INC	Technik-/Wissenschafts-/F&E-Leiter	16.12.2015	-

Duke University School of Medicine	Doctorate Degree
The College of William & Mary	Undergraduate Degree

International

Vereinigte Staaten

Operativ

Chief Tech/Sci/R&D Officer	3
Corporate Officer/Principal	2
Doctorate Degree	1

Sektoral

Health Technology	5
Consumer Services	3

Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Börsennotierte Unternehmen	2
BRISTOL-MYERS SQUIBB COMPANY	Health Technology
ARCUS BIOSCIENCES, INC.	Health Technology

Private Unternehmen	2
DNIB Unwind, Inc. DNIB Unwind, Inc. BiotechnologyHealth Technology DNIB Unwind, Inc. develops biopharmaceutical preparations. The company was founded by Omid C. Farokhzad and Robert S. Langer on May 19, 2006 and is headquartered in Los Angeles, CA.	Health Technology
Idera Pharmaceuticals, Inc. Idera Pharmaceuticals, Inc. BiotechnologyHealth Technology Idera Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which focuses on the clinical development, and commercialization of drug candidates for both oncology and rare disease indications. The company was founded by Paul C. Zamecnik, Sudhir A. Agrawal, and James B. Wyngaarden on May 25, 1989 and is headquartered in Exton, PA.	Health Technology

Private Unternehmen

Health Technology